Bellevue Group’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Sell |
15,556
-943
| -6% | -$12.8K | ﹤0.01% | 123 |
|
|
2025
Q1 | $262K | Hold |
16,499
| – | – | 0.01% | 130 |
|
|
2024
Q4 | $203K | Hold |
16,499
| – | – | ﹤0.01% | 143 |
|
|
2024
Q3 | $200K | Sell |
16,499
-1,000
| -6% | -$12.1K | ﹤0.01% | 147 |
|
|
2024
Q2 | $205K | Buy |
17,499
+8,299
| +90% | +$97.1K | ﹤0.01% | 146 |
|
|
2024
Q1 | $119K | Buy |
+9,200
| New | +$119K | ﹤0.01% | 159 |
|